Cefepime-induced encephalopathy in a COVID-19 patient: a case report

Prolonged neurological symptoms such as “brain fog” and cognitive impairment have occurred after coronavirus disease 2019 (COVID-19) infection. In this report, we describe impaired consciousness caused by cefepime hydrochloride (CFPM) in a patient with cognitive sequalae of COVID-19. A 56-year-old m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tomoyuki, Yatabe, Tomoaki, Kuriyama, Naohide, Hiraiwa, Toshihisa, Matsumoto, Kana, Nishida, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053838/
https://www.ncbi.nlm.nih.gov/pubmed/35487992
http://dx.doi.org/10.1007/s00540-022-03068-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053838/
https://www.ncbi.nlm.nih.gov/pubmed/35487992
http://dx.doi.org/10.1007/s00540-022-03068-1

Ejemplares similares